Cerebrospinal fluid amyloid-beta as potential biomarker for cognitive functioning in multiple sclerosis

M. Van Dam; E. Willemse; I. Nauta; M. Huiskamp; M. Klein; B. Moraal; J. Geurts; B. Uitdehaag; C. Teunissen; B. De Jong; H. Hulst

Cerebrospinal fluid amyloid-beta as potential biomarker for cognitive functioning in multiple sclerosis

M. Van Dam, E. Willemse, I. Nauta, M. Huiskamp, M. Klein, B. Moraal, J. Geurts, B. Uitdehaag, C. Teunissen, B. De Jong, H. Hulst

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	495-496
Journal	Multiple Sclerosis Journal
Volume	26
Issue number	3_SUPPL
Publication status	Published - Dec 2020

Cite this

@article{5d0f418340224116a685fd536c0f48ec,

title = "Cerebrospinal fluid amyloid-beta as potential biomarker for cognitive functioning in multiple sclerosis",

author = "{Van Dam}, M. and E. Willemse and I. Nauta and M. Huiskamp and M. Klein and B. Moraal and J. Geurts and B. Uitdehaag and C. Teunissen and {De Jong}, B. and H. Hulst",

year = "2020",

month = dec,

language = "English",

volume = "26",

pages = "495--496",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications",

number = "3_SUPPL",

}

TY - JOUR

T1 - Cerebrospinal fluid amyloid-beta as potential biomarker for cognitive functioning in multiple sclerosis

AU - Van Dam, M.

AU - Willemse, E.

AU - Nauta, I.

AU - Huiskamp, M.

AU - Klein, M.

AU - Moraal, B.

AU - Geurts, J.

AU - Uitdehaag, B.

AU - Teunissen, C.

AU - De Jong, B.

AU - Hulst, H.

PY - 2020/12

Y1 - 2020/12

M3 - Meeting Abstract

VL - 26

SP - 495

EP - 496

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

SN - 1352-4585

IS - 3_SUPPL

ER -